StockData
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. (ETON) stock

ETONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30521% above fair value
$63.65−0.23 (-0.36%)

Close on Nov 17, 2026Market cap $1.82BP/E 163.2Yield –

Eton Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Eton Pharmaceuticals's total debt was $27.90M at Jun 30, 2026. For fiscal 2025 it was $30.56M, up 2.5% from the year before. The highest annual figure on record is $30.56M in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$30.56M+2.5%
FY2024Dec 31, 2024$29.81M+454.1%
FY2023Dec 31, 2023$5.38M+420.8%
FY2022Dec 31, 2022$1.03M-27.2%
FY2021Dec 31, 2021$1.42M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$27.90M-7.5%
Q1 FY2026Mar 31, 2026$30.75M+3.1%
Q4 FY2025Dec 31, 2025$30.56M+640.8%
Q3 FY2025Sep 30, 2025$30.37M+551.9%
Q2 FY2025Jun 30, 2025$30.18M+501.2%
Q4 FY2024Dec 31, 2024$29.81M+454.1%
Q3 FY2024Sep 30, 2024$4.13M+167.9%
Q2 FY2024Jun 30, 2024$4.66M+202.5%
Q1 FY2024Mar 31, 2024$5.02M+274.9%
Q4 FY2023Dec 31, 2023$5.38M+420.8%
Q3 FY2023Sep 30, 2023$1.54M+117.5%
Q2 FY2023Jun 30, 2023$1.54M+323.1%
Q1 FY2023Mar 31, 2023$1.34M-5.6%
Q4 FY2022Dec 31, 2022$1.03M-5.4%
Q3 FY2022Sep 30, 2022$708.00K-5.5%
Q2 FY2022Jun 30, 2022$364.00K-5.5%
Q4 FY2021Dec 31, 2021$1.42M–
Q3 FY2021Sep 30, 2021$1.09M–
Q2 FY2021Jun 30, 2021$749.00K–
Q1 FY2021Mar 31, 2021$385.00K–

More Eton Pharmaceuticals figures

See a number that looks wrong?